MARKET

XBIO

XBIO

Xenetic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.010
-0.062
-5.78%
Opening 13:40 02/27 EST
OPEN
1.040
PREV CLOSE
1.072
HIGH
1.050
LOW
0.9413
VOLUME
354.62K
TURNOVER
--
52 WEEK HIGH
39.00
52 WEEK LOW
0.9300
MARKET CAP
5.81M
P/E (TTM)
-0.0791
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of XBIO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

XBIO News

More
  • Xenetic Biosciences' Webcast Replay from Noble Capital Markets' 16th Annual Investor Conference Presentation Now Available
  • ACCESSWIRE · 5h ago
  • Xenetic Biosciences, Inc. Appoints Accomplished Biopharmaceutical Executive, Greg MacMichael, Ph.D. to Scientific Advisory Board
  • ACCESSWIRE · 1d ago
  • Xenetic Biosciences, Inc. Strengthens Expertise to Advance XCART Development Program with Appointment of Cell Therapy Expert, Maksim Mamonkin, Ph.D. to Scientific Advisory Board
  • ACCESSWIRE · 02/13 13:00
  • Xenetic Biosciences, Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference
  • ACCESSWIRE · 02/11 13:05

Industry

Biotechnology & Medical Research
-2.04%
Pharmaceuticals & Medical Research
-1.37%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About XBIO

Xenetic Biosciences, Inc. is a biopharmaceutical company. The Company is focused on progressing XCART, a personalized chimeric antigen receptor (CAR) T platform technology engineered to target patient-specific tumor neoantigens. The Company is advancing cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. The Company is leveraging PolyXen, its drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen enables biological drugs by modifying their half-life and other pharmacological properties.
More

Webull offers kinds of Xenetic Biosciences Inc stock information, including NASDAQ:XBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XBIO stock news, and many more online research tools to help you make informed decisions.